Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Eleana Ntatsaki"'
Autor:
Maciej Debski, Vasiliki Tsampasian, Shawn Haney, Katy Blakely, Samantha Weston, Eleana Ntatsaki, Mark Lim, Susan Madden, Aris Perperoglou, Vassilios S Vassiliou
Publikováno v:
PLOS Global Public Health, Vol 2, Iss 11, p e0001188 (2022)
Post-COVID syndrome, defined as symptoms persisting for more than twelve weeks after the diagnosis of COVID-19, has been recognised as a new clinical entity in the context of SARS-CoV-2 infection. This study was conducted to characterise the burden a
Externí odkaz:
https://doaj.org/article/52aa0b2755c74ebfa9e0a75ac2ffd890
Autor:
Vasiliki Tsampasian, Hussein Elghazaly, Rahul Chattopadhyay, Maciej Debski, Thin Kyi Phyu Naing, Pankaj Garg, Allan Clark, Eleana Ntatsaki, Vassilios S. Vassiliou
Publikováno v:
JAMA Internal Medicine.
ImportancePost−COVID-19 condition (PCC) is a complex heterogeneous disorder that has affected the lives of millions of people globally. Identification of potential risk factors to better understand who is at risk of developing PCC is important beca
Autor:
Sarah Fordham, Eleana Ntatsaki
Publikováno v:
Rheumatology Advances in Practice. 6
Introduction/Background This case highlights the extent of multi-organ involvement that can be seen with scleroderma, or in our patients’ case, a scleroderma myositis overlap. It presents many diagnostic and management challenges and highlights the
Publikováno v:
Lupus. 28:651-657
Objectives Poor adherence to immunosuppressive treatment is common in patients with systemic lupus erythematosus and may identify those with lupus nephritis (LN) who have a poorer prognosis. Non-adherence has also been reported to be a potential adve
Publikováno v:
Ultrasound in Medicine & Biology. 45:452-460
Systemic lupus erythematosus (SLE) and primary Sjögren's syndrome (SS) can be associated with inflammatory arthritis, which is underdiagnosed by clinical examination. The aim of this cross-sectional, observational study was to compare, for the first
Publikováno v:
Oxford Medical Case Reports
Publikováno v:
Clinical Rheumatology
Lupus nephritis (LN) is an important cause of morbidity and mortality in patients with systemic lupus erythematosus (SLE) often leading to end-stage renal failure (ESRF) and necessitating renal transplantation (rTp). Optimal timing of rTp in SLE pati
Publikováno v:
Expert Opinion on Drug Safety. 15:1041-1054
The management of lupus nephritis (LN) has changed significantly over the last 10 years due to emerging evidence from large randomised clinical trials that produced good quality data and guided the formulation of two key concepts: the induction of re
Publikováno v:
THURSDAY, 14 JUNE 2018.
Background Lupus nephritis (LN) is an important cause of morbidity and mortality in patients with systemic lupus erythematosus (SLE) often leading to end stage renal failure (ESRF) and necessitating renal transplantation. However, the optimal timing
Publikováno v:
Public health, health services research and health economics.
Background Good adherence to prescribed pharmacotherapy is often over-estimated by physicians. Although in Systemic Lupus Erythematous (SLE) non-adherence is well-researched,1 less research exists for vasculitis. Objectives We compared cohorts of pat